Yan Li

Yan Li is currently working as a Contract/Senior Biostatistician at IDDI, leading Phase 3 Triple Negative Breast Cancer and IDMC studies. Prior to this, Yan has held various biostatistician roles at companies like Parexel, Cytel, GCE Solutions Inc., INC Research, PPD, and Saint Luke's Health System. Yan holds a PhD in Biostatistics from Florida State University, a Master's degree in Biostatistics from Florida State University, a Master's degree in Chemistry from the Institute of Chemistry, Chinese Academy of Sciences, and a Bachelor's degree in Polymer Materials and Engineering from Jinan University.